The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target.

about

The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target.

Item

http://www.wikidata.org/entity/Q38896673

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Evolution of the Sigma-2 ( ...... Bona Fide Therapeutic Target.

@en

type

Item

label

The Evolution of the Sigma-2 ( ...... Bona Fide Therapeutic Target.

@en

prefLabel

The Evolution of the Sigma-2 ( ...... Bona Fide Therapeutic Target.

@en

P1476

The Evolution of the Sigma-2 ( ...... Bona Fide Therapeutic Target.

@en

P2093

Chenbo Zeng

http://www.w3.org/2001/XMLSchema#string

Robert H Mach

http://www.w3.org/2001/XMLSchema#string

P2860

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity

Progesterone receptor membrane component 1: an integrative review.

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer

The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.

Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.

Interaction of the sigma(2) receptor ligand PB28 with the human nucleosome: computational and experimental probes of interaction with the H2A/H2B dimer.

P304

49-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-50174-1_5

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

964

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28315264

http://www.w3.org/2001/XMLSchema#string